OppFi: The Market Threw the Baby Out With the Subprime Bathwater — Or Did It?

# OppFi: The Market Threw the Baby Out With the Subprime Bathwater — Or Did It?

Here's a stock that makes you want to open two separate browser tabs and never let them talk to each other. Tab one: a company trading at roughly 5x forward earnings, buying back its own stock hand over fist, and fresh off a courtroom win that just neutered its scariest regulatory threat. Tab two: a lender whose credit book is visibly cracking, whose growth just stalled out, and whose management team just told Wall Street to lower its expectations. Both tabs are OppFi. Welcome to OPFI.

Let's start with the gut punch. OppFi reported Q2 2026 results on August 9–10, and it was ugly by any measure — EPS of $0.33 against a $0.45 consensus, a 31% miss, revenue light by about 9%, and a guidance cut for the rest of the year. The stock did what stocks do when a subprime lender says the word "credit cycle" out loud: it tanked. And this wasn't a bolt out of the blue — Q1 had already flashed the warning lights, with "record revenue" headlines masking originations that were shrinking and credit quality that was quietly deteriorating underneath. Q2 just confirmed the pattern instead of breaking it. If you were hoping this was a one-quarter stumble, the setup says otherwise.

So why is this name still lighting up value screens instead of getting left for dead? Two words: valuation and vindication.

On valuation, the compression here is genuinely extreme — forward P/E has been cited as low as ~5x post-selloff, with some readings even lower. Management clearly agrees the stock is cheap: OppFi bought back $11.2 million of stock in H1 2026 at an average price of $9.46, and it's now working through a fresh $40 million authorization approved back in May. That's not a symbolic gesture — that's a company putting real capital behind the belief that the market has overcorrected.

On vindication, this is the part bulls will hang their hat on: the California "true lender" case. A California Superior Court finalized its Statement of Decision in OppFi's favor in May 2026, rejecting the DFPI's argument that OppFi — not its bank partner FinWise — was really the lender under the state's Fair Access to Credit Act. The court found FinWise, not OppFi, controlled underwriting, funded the loans, held title, and bore first-loss risk. That's a big deal. This case has been an overhang on the bank-partnership lending model since 2022, and a clean win at the trial court level is a meaningful de-risking event — one that arrived at almost the exact moment the earnings narrative turned sour, which is probably why it hasn't been fully priced in either direction.

But don't let the legal win distract from the actual business risk, which is credit, full stop. Rising charge-offs across two straight quarters, a guidance cut, institutional investors reportedly trimming positions, and a prior profit picture that leaned partly on a one-time $12 million warrant gain rather than pure lending economics — that's not a company firing on all cylinders, that's a company managing a credit cycle in real time while simultaneously trying to execute a $131 million bank holding company acquisition. That acquisition is strategically sound on paper (cheaper funding costs, less reliance on third-party bank partners) but it's also complex, capital-intensive, and adds regulatory execution risk right when the core lending book needs undivided attention.

My read: this is a stock where the market is pricing in credit-cycle fear pretty aggressively, and the "removed tail risk" from the California ruling genuinely hasn't caught up in the multiple. That's the interesting tension. But "cheap" isn't the same as "safe" — a 5x multiple on earnings that keep missing by 30%+ isn't a bargain, it's a discount rate on uncertainty. The buyback puts a floor under the stock at management's own conviction price near $9.50; the credit cycle puts a ceiling on how much anyone should pay above it until charge-offs actually stabilize.

Q3 earnings land November 4, with consensus sitting at $0.41 EPS. That print — not the legal headlines, not the buyback pace — is the real referee here. Until then, OPFI is a stock for people who like their value plays served with a side of subprime anxiety. Bring antacids.